Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sucampo Pharmaceuticals Inc (NASDAQ:SCMP)

11.80
Delayed Data
As of Sep 22
 -0.05 / -0.42%
Today’s Change
9.30
Today|||52-Week Range
17.55
-12.92%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2016
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Revenue and IncomeNet Revenues57.9M73.0M56.3M59.9M
 
 
 
 
 
Cost of Goods Sold7.8M8.9M9.5M9.6M
 
 
 
 
 
Depreciation And Amortization7.8M7.8M7.4M7.5M
 
 
 
 
 
 
Operating ExpensesGross Income42.3M56.3M39.4M42.9M
 
 
 
 
 
General Expenses20.9M22.8M28.2M31.9M
 
 
 
 
 
Research And Development10.0M11.0M10.3M19.1M
 
 
 
 
 
Total Operating Expenses36.5M39.5M45.1M48.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income21.4M33.5M11.2M11.0M
 
 
 
 
 
Extraordinary Charge-8.1M-14.0M-365.0K-186.8M
 
 
 
 
 
Interest Expense On Debt5.9M5.6M2.9M2.9M
 
 
 
 
 
Other Expenses8.1M-7.0M211.0K-476.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income15.5M6.9M8.2M-179.2M
 
 
 
 
 
Income Taxes-7.4M-8.4M-3.6M-1.9M
 
 
 
 
 
Net Income8.1M15.3M4.6M-181.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS42.8M43.0M43.4M46.2M
 
 
 
 
 
Shares To Calculate EPS Diluted43.4M44.9M62.1M46.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.19$0.34$0.10-$3.92
 
 
 
 
 
EPS Diluted$0.19$0.34$0.10-$3.92